BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

624 related articles for article (PubMed ID: 2995487)

  • 1. Cellular tropism of the human retrovirus HTLV-III/LAV. I. Role of T cell activation and expression of the T4 antigen.
    McDougal JS; Mawle A; Cort SP; Nicholson JK; Cross GD; Scheppler-Campbell JA; Hicks D; Sligh J
    J Immunol; 1985 Nov; 135(5):3151-62. PubMed ID: 2995487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV).
    Nicholson JK; Cross GD; Callaway CS; McDougal JS
    J Immunol; 1986 Jul; 137(1):323-9. PubMed ID: 3011909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of effector mechanisms against HTLV-I- and HTLV-III/LAV-infected lymphoid cells.
    Ruscetti FW; Mikovits JA; Kalyanaraman VS; Overton R; Stevenson H; Stromberg K; Herberman RB; Farrar WL; Ortaldo JR
    J Immunol; 1986 May; 136(10):3619-24. PubMed ID: 2422259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility of normal human lymphocytes to infection with HTLV-III/LAV.
    Folks T; Kelly J; Benn S; Kinter A; Justement J; Gold J; Redfield R; Sell KW; Fauci AS
    J Immunol; 1986 Jun; 136(11):4049-53. PubMed ID: 2422271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of the human retrovirus HTLV-III/LAV/ARV/HIV to the CD4 (T4) molecule: conformation dependence, epitope mapping, antibody inhibition, and potential for idiotypic mimicry.
    McDougal JS; Nicholson JK; Cross GD; Cort SP; Kennedy MS; Mawle AC
    J Immunol; 1986 Nov; 137(9):2937-44. PubMed ID: 2428879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amplification of HTLV-III/LAV infection by antigen-induced activation of T cells and direct suppression by virus of lymphocyte blastogenic responses.
    Margolick JB; Volkman DJ; Folks TM; Fauci AS
    J Immunol; 1987 Mar; 138(6):1719-23. PubMed ID: 3493285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional characterization of human thymocytes: a limiting dilution analysis of precursors with proliferative and cytolytic activities.
    Lopez-Botet M; Moretta L
    J Immunol; 1985 Apr; 134(4):2299-304. PubMed ID: 3919089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional modifications of alloreactive T cell clones infected with HTLV-I.
    Suciu-Foca N; Rubinstein P; Rohowsky-Kochan C; Cai J; Popovic M; Gallo RC; King DW
    J Immunol; 1986 Aug; 137(4):1115-9. PubMed ID: 3016087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-2 receptor (Tac antigen) expressed on adult T cell leukemia cells.
    Uchiyama T; Hori T; Tsudo M; Wano Y; Umadome H; Tamori S; Yodoi J; Maeda M; Sawami H; Uchino H
    J Clin Invest; 1985 Aug; 76(2):446-53. PubMed ID: 2993359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficiency of the autologous mixed lymphocyte reaction in patients with classic hemophilia treated with commercial factor VIII concentrate. Correlation with T cell subset distribution, antibodies to lymphadenopathy-associated or human T lymphotropic virus, and analysis of the cellular basis of the deficiency.
    Smolen JS; Bettelheim P; Köller U; McDougal S; Graninger W; Luger TA; Knapp W; Lechner K
    J Clin Invest; 1985 Jun; 75(6):1828-34. PubMed ID: 2989334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 2 (IL 2) up-regulates its own receptor on a subset of human unprimed peripheral blood lymphocytes and triggers their proliferation.
    Harel-Bellan A; Bertoglio J; Quillet A; Marchiol C; Wakasugi H; Mishall Z; Fradelizi D
    J Immunol; 1986 Apr; 136(7):2463-9. PubMed ID: 3005412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of interleukin 2 and T11 E rosette antigen in activation and proliferation of human NK clones.
    Schmidt RE; Hercend T; Fox DA; Bensussan A; Bartley G; Daley JF; Schlossman SF; Reinherz EL; Ritz J
    J Immunol; 1985 Jul; 135(1):672-8. PubMed ID: 3923116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [AIDS physiopathology and epidemiology of the infection with the LAV virus].
    Gluckman JC
    Rev Epidemiol Sante Publique; 1986; 34(2):112-7. PubMed ID: 3016830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity.
    Sodroski J; Goh WC; Rosen C; Campbell K; Haseltine WA
    Nature; 1986 Jul 31-Aug 6; 322(6078):470-4. PubMed ID: 3016552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin 2 production in HTLV-III/LAV infection: evidence of defective antigen-induced, but normal mitogen-induced IL-2 production.
    Antonen J; Krohn K
    Clin Exp Immunol; 1986 Sep; 65(3):489-96. PubMed ID: 2946497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-2 receptor expression in retrovirus associated adult T-cell leukemia.
    Waldmann TA; Leonard WJ; Depper JM; Krönke M; Goldman CK; Oh T; Greene WC
    Princess Takamatsu Symp; 1984; 15():259-68. PubMed ID: 6100644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule.
    McDougal JS; Kennedy MS; Sligh JM; Cort SP; Mawle A; Nicholson JK
    Science; 1986 Jan; 231(4736):382-5. PubMed ID: 3001934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TCGF(IL 2)-receptor inducing factor(s). II. Possible role of ATL-derived factor (ADF) on constitutive IL 2 receptor expression of HTLV-I(+) T cell lines.
    Okada M; Maeda M; Tagaya Y; Taniguchi Y; Teshigawara K; Yoshiki T; Diamantstein T; Smith KA; Uchiyama T; Honjo T
    J Immunol; 1985 Dec; 135(6):3995-4003. PubMed ID: 2999237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional characterization of human T lymphocyte subsets distinguished by monoclonal anti-leu-8.
    Kansas GS; Wood GS; Fishwild DM; Engleman EG
    J Immunol; 1985 May; 134(5):2995-3002. PubMed ID: 3156924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies to the CD5 antigen can provide the necessary second signal for activation of isolated resting T cells by solid-phase-bound OKT3.
    Ceuppens JL; Baroja ML
    J Immunol; 1986 Sep; 137(6):1816-21. PubMed ID: 3091691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.